Radical Inguinal Orchiectomy
Treatment for Testicular cancer
Typical Dosage: Surgical procedure
Effectiveness
98%
Safety Score
70%
Clinical Trials
1
Participants
1M
Comparative Safety Scale(Higher is safer)
Cyanideβ οΈ
Methπ
Cigarettesπ¬
Chemoβ’οΈ
AlcoholπΊ
Morphineπ
Antibioticsπ
Tylenolπ
Exerciseπ
Waterπ§
70
DangerousModerateSafe
Treatment Details
Dosage Range
Surgical procedure
Time to Effect
Immediate (tumor removal)
Treatment Duration
Single procedure
Evidence Quality
HIGHConfidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$200
Monitoring:$3,000
Side Effect Mgmt:$500
Total Annual:$13,700
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$10,000/QALY
QALYs Gained
25
Outcome-Based Costs
Cost per Remission
$16,118
Radical Inguinal Orchiectomy Outcomes
for Testicular cancer
Efficacy Outcomes
Overall Effectiveness
+98%
Response Rate
+100%
Remission Rate
+85%
Common Side Effects
Post-operative pain
+80%
Scrotal swelling/hematoma
+10%
Wound infection
+3%
Nerve damage/numbness
+1%
Sources:
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
1 active trial recruiting for Radical Inguinal Orchiectomy in Testicular cancer
Patient Reported Experiences With Sparing External Oblique Fascia Vs Standard Inguinal Orchiectomy
NCT06828185RECRUITINGNA
80 participants
INTERVENTIONAL
Loma Linda, United States
Started: May 1, 2026